Sort   by:  
 Page size 
MetabolomicsMultiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level (Metabolite profiling)

Medulloblastomas (MBs) are malignant pediatric brain tumors that are molecularly and clinically very heterogenous. The application of omics technologies - mainly studying nucleic acids - has significantly improved MB classification and stratification, but treatment options are still unsatisfactor...

2024-05-30 | MTBLS9830 | MetaboLights
ProteomicsPharmacoproteomic characterisation of human colon and rectal cancer - CRC65 Full Proteomes
Most molecular cancer therapies act on protein targets but data on the proteome status of patients and cellular models are only beginning to emerge. Here, we profiled the proteomes of 65 colorectal cancer (CRC) cell lines to a depth of >10,000 proteins using mass spectrometry. Integration with prote...
ORGANISM(S): Homo sapiens (Human) 
2017-12-12 | PXD005354 | Pride
Personalised medicine Integrated full proteome subtypes Crc65 Mass spectrometry Correlation of mrna and protein abundance Patient stratification Consensus molecular subtypes Cptac Quasar2 Kinobeads 
ProteomicsPharmacoproteomic characterisation of human colon and rectal cancer - CPTAC Full Proteomes
Most molecular cancer therapies act on protein targets but data on the proteome status of patients and cellular models are only beginning to emerge. Here, we profiled the proteomes of 65 colorectal cancer (CRC) cell lines to a depth of >10,000 proteins using mass spectrometry. Integration with prote...
ORGANISM(S): Homo sapiens (Human) 
2017-12-13 | PXD005353 | Pride
Personalised medicine Integrated full proteome subtypes Crc65 Mass spectrometry Correlation of mrna and protein abundance Patient stratification Consensus molecular subtypes Cptac Quasar2 Kinobeads 
ProteomicsPharmacoproteomic characterisation of human colon and rectal cancer - CRC65 Full Proteomes
Most molecular cancer therapies act on protein targets but data on the proteome status of patients and cellular models are only beginning to emerge. Here, we profiled the proteomes of 65 colorectal cancer (CRC) cell lines to a depth of >10,000 proteins using mass spectrometry. Integration with prote...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2017-11-23 | MSV000081738 | MassIVE
ProteomicsPharmacoproteomic characterisation of human colon and rectal cancer - CPTAC Full Proteomes
Most molecular cancer therapies act on protein targets but data on the proteome status of patients and cellular models are only beginning to emerge. Here, we profiled the proteomes of 65 colorectal cancer (CRC) cell lines to a depth of >10,000 proteins using mass spectrometry. Integration with prote...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2017-11-23 | MSV000081739 | MassIVE
ProteomicsPharmacoproteomic characterisation of human colon and rectal cancer - CRC65 Kinobeads
Most molecular cancer therapies act on protein targets but data on the proteome status of patients and cellular models are only beginning to emerge. Here, we profiled the proteomes of 65 colorectal cancer (CRC) cell lines to a depth of >10,000 proteins using mass spectrometry. Integration with prote...
ORGANISM(S): Homo sapiens (Human) 
2017-12-12 | PXD005355 | Pride
Personalised medicine Integrated full proteome subtypes Crc65 Mass spectrometry Correlation of mrna and protein abundance Patient stratification Consensus molecular subtypes Cptac Quasar2 Kinobeads 
ProteomicsQuantitative proteomic analysis identifies TUBB2A as a novel protein biomarker for prediction of distant metastatic breast cancer
Metastasis of breast cancer to other distant organs is fatal to patients. However, few studies have revealed biomarkers associated with distant metastatic breast cancer. Furthermore, the inability of current biomarkers such as HER2, ER and PR, in accurately differentiating between distant metastatic...
ORGANISM(S): Homo sapiens (Human) 
2020-06-05 | PXD016061 | Pride
Formalin-fixed paraffin-embedded (ffpe) tissue Distant metastatic breast cancer Tandem mass tag (tmt) Quantitative proteomics Biomarkers 
ProteomicsProteome Landscape of Early Stage Hepatocellular Carcinoma Identifies Proteomic Subtypes and New Therapeutic Targets - Phosphorylation data
Hepatocellular carcinoma (HCC) accounts for approximately 90% of primary liver cancers, the second leading cause of cancer mortality worldwide. Although HCC surgical treatment may be curative in the early stages, its five-year overall survival is only 50-70%. Advances in proteomic technologies have ...
ORGANISM(S): Homo sapiens (Human) 
2019-03-01 | PXD008373 | Pride
Therapeutic targets Phosphoproteome Hepatocellular carcinoma 
ProteomicsReference proteome of highly purified human Th1 cells reveals strong effects on metabolism and protein ubiquitination upon differentiation
The differentiation of human CD4+ T cells into different subtypes of T helper cells and regulatory T cells is crucial for an appropriate immunological response. Among all subtypes Th1 cells are the most prominent specific cell type, representing about 50% of all lymphocytes. So far most global prote...
ORGANISM(S): Homo sapiens (Human) 
2015-10-13 | PXD001066 | Pride
Th1 cells Cd4+ Human Lc-ms/ms 
ProteomicsProteogenomic pathogenesis and classification of acute myeloid leukemia
Acute myeloid leukemia is a clinically and genetically heterogenous disease characterized by bone marrow infiltration with immature leukemic blasts that cause bone marrow failure. Patient age, comorbidities and genomic disease characteristics have a profound impact on patient outcome. Here, we prese...
ORGANISM(S): Homo sapiens (Human) 
2022-03-08 | PXD022894 | Pride
Transcriptome Mitochondria Proteome Acute myeloid leukemia 
Sort   by:  
 Page size